<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04244942</url>
  </required_header>
  <id_info>
    <org_study_id>S025/2018</org_study_id>
    <nct_id>NCT04244942</nct_id>
  </id_info>
  <brief_title>CERAMENT™| Bone Void Filler Device Registry</brief_title>
  <official_title>CERAMENT™| Bone Void Filler Device Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BONESUPPORT AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BONESUPPORT AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A device registry to compile data on the performance of CERAMENT BONE VOID FILLER in normal
      use.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 30, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>12 months</time_frame>
    <description>Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>24 months</time_frame>
    <description>Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>12 months</time_frame>
    <description>Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>24 months</time_frame>
    <description>Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>12 and 24 months</time_frame>
    <description>Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>12 months</time_frame>
    <description>Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>adverse device events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>24 months</time_frame>
    <description>Adverse device events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>12 months</time_frame>
    <description>SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</measure>
    <time_frame>24 months</time_frame>
    <description>SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiological assessment at 6 and 12 months. Objective assessment of regeneration</measure>
    <time_frame>6 Months</time_frame>
    <description>Bone healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological assessment at 6 and 12 months. Objective assessment of regeneration</measure>
    <time_frame>12 Months</time_frame>
    <description>Bone healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain VAS score</measure>
    <time_frame>6, 12, and 24 Months</time_frame>
    <description>Pain assessment at 6,12, and 24 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-3L</measure>
    <time_frame>6, 12, and 24 months</time_frame>
    <description>Functional assessment at 6, 12, and 24 months</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Orthopedic Disorder</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CERAMENT BVF</intervention_name>
    <description>CERAMENT BONE VOID FILLER is a synthetic biphasic bone graft substitute.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The racial, gender, and ethnic characteristics of the individuals approached for
        participation in this Observational Registry Study shall reflect the demographics of
        patients that would ordinarily received CERAMENT BVF for the treatment of their condition
        at the designated investigative centers. No individuals shall be excluded from
        participation in the Observational Registry Study based on race, nationality, ethnicity,
        gender or sexuality.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years and over (on the day of surgery)

          -  Receive CERAMENT BVF as a component of their treatment at a participating, contracted
             center or healthcare provider, in accordance with the IFU for the implanted product

          -  In receipt of patient information leaflet and have signed appropriately designed
             informed consent

        Exclusion Criteria:

          -  Any exclusion criteria as per IFU for CERAMENT BVF

          -  Any off-label use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brian M Bartholdi</last_name>
    <phone>6178923927</phone>
    <email>brian.bartholdi@bonesupport.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Moore</last_name>
      <email>momfreed@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Janos Ertl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karl Shively, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Watters, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Camden Burns, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Bellamy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cale Jacobs, PhD</last_name>
      <phone>859-797-8197</phone>
      <email>cale.jacobs@uky.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Duncan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OrthoCarolina</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Norwood</last_name>
      <phone>704-323-2267</phone>
      <email>justin.norwood@orthocarolina.com</email>
    </contact>
    <investigator>
      <last_name>Carroll P Jones, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kent Ellington, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Shawen, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Todd Irwin, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>January 15, 2020</study_first_submitted>
  <study_first_submitted_qc>January 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

